Bruker (BRKR)
(Real Time Quote from BATS)
$65.54 USD
0.00 (0.00%)
Updated May 31, 2024 03:36 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
BRKR 65.54 0.00(0.00%)
Will BRKR be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BRKR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BRKR
Bruker (BRKR) Gains Market Share on Innovation Amid Macro Woes
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
BRKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
2 Instruments Stocks to Watch From a Prospering Industry
Investing in Bruker (BRKR)? Don't Miss Assessing Its International Revenue Trends
Down -22.53% in 4 Weeks, Here's Why Bruker (BRKR) Looks Ripe for a Turnaround
Other News for BRKR
Bruker: A Confusing Acquisition Spree
Why Bruker (BRKR) Shares Are Falling During Thursday's Session
What You Missed On Wall Street This Morning
Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024